2.89
Schlusskurs vom Vortag:
$2.88
Offen:
$2.87
24-Stunden-Volumen:
671.46K
Relative Volume:
1.71
Marktkapitalisierung:
$273.26M
Einnahmen:
$72.76M
Nettoeinkommen (Verlust:
$35.34M
KGV:
7.8256
EPS:
0.3693
Netto-Cashflow:
$-62.91M
1W Leistung:
+26.20%
1M Leistung:
+29.02%
6M Leistung:
+40.29%
1J Leistung:
+109.42%
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CGEN
Compugen Ltd
|
2.89 | 272.32M | 72.76M | 35.34M | -62.91M | 0.3693 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-07 | Eingeleitet | Lake Street | Buy |
| 2026-01-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-26 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2020-05-13 | Eingeleitet | Stifel | Buy |
| 2020-05-07 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-22 | Eingeleitet | ROTH Capital | Buy |
| 2020-03-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-03-29 | Eingeleitet | Oppenheimer | Outperform |
| 2016-02-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-23 | Fortgesetzt | Jefferies | Buy |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-02-07 | Eingeleitet | MLV & Co | Buy |
| 2009-12-28 | Bestätigt | Cantor Fitzgerald | Buy |
| 2009-07-29 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Compugen Ltd Aktie (CGEN) Neueste Nachrichten
CGEN SEC FilingsCompugen 10-K, 10-Q, 8-K Forms - Stock Titan
Compugen Q1 2025 Earnings Preview - MSN
Ophir Eran (CGEN) files to sell 5,000 Ordinary shares under option plan - Stock Titan
CGEN (Nasdaq) Rule 144: 2,000-option shares to be sold; prior 26,375 sale - Stock Titan
Compugen (NASDAQ: CGEN) SVP exercises options, sells 3,125 shares under plan - Stock Titan
Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference - Yahoo Finance
Levine Zurit sells 24,375 CGEN ordinary shares (CGEN) - Stock Titan
Aug Update: Can Compugen Ltd maintain sales growth2026 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
VIX Spike: Will Compugen Ltd outperform the market in YEARMarket Volume Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn
Compugen CEO Anat Cohen-Dayag to transition to executive chair - MSN
Eran Perry Net Worth (2026) - GuruFocus
Michelle Mahler Net Worth (2026) - GuruFocus
Savitzky Kinneret Livnat Net Worth (2026) - GuruFocus
Gilead Halevy Net Worth (2026) - GuruFocus
Insider Selling: Compugen (NASDAQ:CGEN) SVP Sells 5,375 Shares of Stock - MarketBeat
Compugen (CGEN) SVP exercises options and sells 7,875 Ordinary Shares - Stock Titan
Aug Update: Whats the analyst consensus on Compugen LtdWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference - Yahoo Finance
Compugen Price Target Announced at $6.00/Share by Lake Street - Moomoo
Compugen (CGEN) Initiates Coverage with 'Buy' Rating by Lake Str - GuruFocus
Compugen (CGEN) Initiates Coverage with 'Buy' Rating by Lake Street | CGEN Stock News - GuruFocus
Compugen (NASDAQ:CGEN) Coverage Initiated by Analysts at Lake Street Capital - MarketBeat
Lake Street Initiates Compugen(CGEN.US) With Buy Rating, Announces Target Price $6 - Moomoo
Lake Street initiates coverage of Compugen (CGEN) with buy recommendation - MSN
Compugen (NASDAQ:CGEN) CEO Sells $12,431.25 in Stock - Defense World
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK
Compugen (CGEN) SVP exercises stock options and sells 3,500 shares under 10b5-1 plan - Stock Titan
Compugen (CGEN) CEO exercises options and sells 5,625 shares in 10b5-1 trade - Stock Titan
Compugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
[144] COMPUGEN LTD SEC Filing - Stock Titan
Wed: Compugen’s big gene dream - גלובס
Compugen (CGEN) SVP uses 10b5-1 plan to exercise options and sell shares - Stock Titan
Risk Check: How is Compugen Ltd managing supply chain issues2026 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
Affiliate to sell 24,375 shares at CGEN (CGEN) — proposed 03/26/2026 - Stock Titan
Compugen (NASDAQ:CGEN) Stock Rating Upgraded by Truist Financial - MarketBeat
RSI Check: Does Compugen Ltd meet Warren Buffetts criteria2026 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
If You Invested $1,000 in Compugen (CGEN) - Stock Titan
Aug Highlights: Is Compugen Ltd stock forming a triangle pattern2026 Performance Recap & Real-Time Volume Surge Alerts - baoquankhu1.vn
Retail Trends: Will Compugen Ltd outperform the market in YEARWeekly Gains Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
Compugen Ltd. (NASDAQ:CGEN) Q4 2025 earnings call transcript - MSN
Compugen shares jump nearly 5% after strong Q4 earnings beat - MSN
Compugen (CGEN) director discloses initial share and option holdings - Stock Titan
CGEN (COMPUGEN LTD) CFO David Silberman discloses initial share and option holdings - Stock Titan
Compugen (CGEN) director discloses initial shares, RSUs and option grants - Stock Titan
Compugen (CGEN) director Eran Perry details shares, RSUs and options - Stock Titan
Compugen (CGEN) CEO Ophir Eran details share and long-dated option holdings - Stock Titan
Compugen (CGEN) CMO Michelle Mahler details option and RSU holdings - Stock Titan
[Form 3] COMPUGEN LTD Initial Statement of Beneficial Ownership - Stock Titan
Compugen (CGEN) director Mathias Hukkelhoven details initial equity holdings - Stock Titan
Compugen (CGEN) director Holcomb reports shares, options and RSUs - Stock Titan
Halevy Gilead discloses initial Compugen (CGEN) share and option holdings - Stock Titan
Finanzdaten der Compugen Ltd-Aktie (CGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):